Biodiversity includes genetic diversity, species diversity, ecosystem diversity, and landscape diversity. Among the four levels of biodiversity, genetic diversity is the core element and the basis of biological evolution. Genetic diversity is the sum of genetic variation among different populations within the same species or among different individuals within the same population and is expressed mainly at the molecular, cellular, and individual levels within populations or among populations. Generally speaking, the level of genetic variation is the most direct expression of the amount of genetic diversity. The study of parasite population genetics can be carried out between or within populations, and genetic diversity depends on the mutation rate of bases, the effective size of the population, and the migration rate of the population. The study of genetic diversity is important for understanding the epidemiological patterns of parasites, the spread of drug-resistant alleles, and the prevention and control of diseases.
Ace Therapeutics provides analysis services for parasite genetic diversity to clients worldwide. Our comprehensive service center for parasite biology, built on our technology platform, emphasizes basic research and can provide a full range of services for parasite genetic diversity research from upstream to downstream.
We provide parasite polymerase chain reaction-restriction fragment length polymorphism (RFLP) technology services to help you perform genetic diversity analysis of parasite populations.
We provide random amplified polymorphic DNA (RAPD) service for parasites. The application of the RAPD molecular marker requires less DNA, is easy to operate and fast to detect, and can detect repetitive sequence regions that cannot be detected by RFLP markers and fill the gap in RFLP profiles.
We provide polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) service and capillary electrophoresis-single strand conformation polymorphism (CE-SSCP) services for parasites. They are characterized by high separation efficiency, fast analysis, low sample usage, and can screen a large number of mutant genes.
We provide amplified fragment length polymorphism (AFLP) service for parasites. AFLP markers combine the advantages of both RFLP and RAPD markers, but the operation is more complicated and expensive.
We provide parasite microsatellite DNA/simple sequence repeat (SSR) or short tandem repeats (STR) technology services, which are mainly used for parasite population genetic structure analysis, construction of the genetic map, and other research.
Note: In addition, there are other technical services available for you to choose from, please consult us for details.
Parasite population genetics provides good theoretical support for further understanding the population genetic characteristics of parasites. The development of molecular genetic marker technology has given great impetus to the study of molecular identification and phylogeny of new parasite species. However, for most of the parasites, genomic and genetic evolutionary information is still unknown, and the lack of such information makes the study of the formation of host populations, host defense, selection pressure, and the development of drug resistance of the parasites very limited. We believe that the continued enrichment of genomic, transcriptomic, proteomic, and metabolomic data on parasites will provide important assistance in the study of molecular taxonomy, population genetics, molecular epidemiology, and parasite control. We offer almost all services related to parasitology, please consult us for details.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.